Literature DB >> 32944525

The inflammation patterns of different inflammatory cells in histological structures of hyperplasic prostatic tissues.

Yisen Meng1,2,3, Wei Yu1,2,3, Zhenhua Liu1,2,3, Muqiu Zhang1,2,3, Yuke Chen1,2,3, Shaobo Li4, Yu Fan1,2,3, Shuai Hu1,2,3, Kai Zhang1,2,3, Qian Zhang1,2,3, Jie Jin1,2,3.   

Abstract

BACKGROUND: The distribution characteristics of inflammatory cells in hyperplastic prostatic tissue and its influences on disease development remain unknown. We aimed to explore the infiltration characteristics of different inflammatory cells in histological structures of benign prostatic hyperplasia (BPH) in combination with clinical data.
METHODS: The present study included 76 cases of BPH patients underwent transurethral resection of prostate (TURP). Hematoxylin-eosin staining was performed to identify the degree of general inflammation in prostatic tissues. The infiltration of T-lymphocytes (CD3), B-lymphocytes (CD20), and macrophages (CD68) were recorded by immunohistochemistry.
RESULTS: The present study included 76 BPH patients with the mean age of 69.5 years old (range, 49-83 years) and the mean prostate volume of 91.9 mL (range, 24-218 mL). Periglandular inflammation was the most common pattern, being presented in 94.7% (72/76) patients, followed by stromal inflammation (67/76, 88.2%) and glandular inflammation (57/76, 75.0%). However, the stroma presented the highest rate of severe inflammation (14.6%). And the grades of glandular inflammation and stromal inflammation were independently correlated with prostate volume. T-lymphocytes, B-lymphocytes and macrophages had different infiltrated patterns in histological structures of prostate. And stromal hyperplasia dominated BPH was only significantly correlated with the T-lymphocytes infiltration condition (P=0.001). Meanwhile, overweight patients had more severe glandular inflammation in the prostate (P=0.010). The grade of glandular inflammation could independently increase prostate-specific antigen (PSA).
CONCLUSIONS: We characterized infiltrated patterns of different inflammatory cells in histological structures of hyperplasic prostatic tissues from surgically treated BPH specimens. The role of inflammation in BPH development was highlighted by its correlation with the prostate volume, metabolism and PSA level. 2020 Translational Andrology and Urology. All rights reserved.

Entities:  

Keywords:  B-lymphocytes; Benign prostatic hyperplasia (BPH); T-lymphocytes; inflammation; macrophages

Year:  2020        PMID: 32944525      PMCID: PMC7475681          DOI: 10.21037/tau-20-448

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


Introduction

Benign prostatic hyperplasia (BPH) is the most frequently diagnosed urological disease in ageing men (1). Histologically, BPH is characterized by the excessive proliferation of both epithelial cells and stromal cells within the transitional zone, causing prostate enlargement and lower urinary tract symptoms (LUTS) (2). BPH is chronically progressive and age dependent, which lead to a diminished health-related quality of life (3). The prevalence of BPH usually initiates after 40 years of age and gradually approaches the peak during 60 to 90 years old (1,3,4). The clinical progression of BPH is recorded, when an elderly man suffers from frequent LUTS or acute urinary retention (5,6). Multiple risk factors have been proposed to contribute to the development of BPH, including ageing, diet, hormonal alterations, and chronic inflammation (3,7). Although the definite cause of BPH remains a dilemma, majority of etiological postulates indicate that the chronic histological inflammation plays an indispensable role in the development of BPH (8,9). The role of inflammation in BPH development is highlighted by the strong correlation between histological inflammation, clinical symptoms, and prostate volume (10). Actually, increased infiltration of macrophages, T-lymphocytes, and B-lymphocytes are frequently detected in prostate tissues from BPH patients (9-11). According to the published literatures, continuous inflammatory tissue damage and subsequent process of repetitive wound healing cause prominent proliferation of stromal and epithelial cells of the prostate (11). However, the distribution characteristics of inflammatory cells in hyperplastic prostatic tissue and its influences on disease development remain unknown. In the present study, we investigated the infiltration condition of different inflammatory cells in glandular, periglandular, and stromal sections of hyperplastic prostatic tissues, and analyzed the correlation between infiltrated inflammation pattern and clinical data of BPH patients. We present the following article in accordance with the STROBE reporting checklist (available at http://dx.doi.org/10.21037/tau-20-448).

Methods

The present study included 76 patients who were diagnosed BPH and underwent transurethral prostatic resection (TURP) from January 2009 to February 2010 in our center. Patients were excluded if they had complaints of perineal, suprapubic or voiding pain, positive urine cultures, catheterization, medication history of 5α-reductase inhibitors, prostatic tumor or history of prostatitis and prostate surgery. The PSA test was performed for two times: about one month before surgery at outpatient department and one day before surgery at inpatient ward. And the mean value of PSA was recorded. Patient’s prostate size was measured by transrectal ultrasound one day before the TURP surgery. This study was approved by the institutional ethics committee (NO.: 2018-403) of our center. Patient records or information were anonymous and de-identified prior to analysis. Written informed consent was obtained from the patient for publication of this study and any accompanying images. This study was also in line with the Helsinki declaration (as revised in 2013). BPH is mainly developed in the transitional zone of the prostate. In TURP, it is the prostate tissues at the transitional zone that are removed and sent for pathological examination. In our center, for every BPH patient, all the TURP tissues are sent for pathological examination. The TURP specimens were formalin fixed, dehydrated, paraffin-embedded and sliced at 5 µm per slice. According to the histopathological classification system for chronic prostatic inflammation proposed by the Chronic Prostatitis Collaborative Research Network (CPCRN) and the International Prostatitis Collaborative Network (IPCN) (11), the histological sections of inflammation were classified as glandular, periglandular, and stromal. The grades of inflammation were characterized by hematoxylin-eosin (H&E) staining from 0 to 3 ().
Table S1

Classification of inflammatory infiltration in prostate

ClassificationDescription
LocalizationHistologic type
   GlandularInflammatory cells infiltrate the glandular/ductal epithelium and/or lumen
   PeriglandularInflammatory cells infiltrate the stroma, centered on a gland/duct, less than 50 μm from the gland/duct
   StromalInflammatory cells infiltrate the stroma, more than 50 μm from the gland/duct
ExtentTissue area involved by inflammatory cell infiltrates
   Focal<10%
   Multifocal10–50%
   Diffuse>50%
GradeMorphological description (density of inflammatory cells, number of cells/mm2)
   1/MildIsolated inflammatory cells, distributed in interstitial spaces (<100)
   2/ModerateInflammatory cells aggregate and appear in sheets, without tissue destruction or lymphoid nodules/follicular formation (100–500)
   3/SevereInflammatory cells aggregate and appear in sheets, with tissue destruction or lymphoid nodules/follicular formation (>500)
First, the tissue slices were stained with H&E. All the H&E sections of one BPH patient were back to back reviewed of by two pathologists. For each case, the prostatic inflammatory infiltrates in each histological structure (glandular, periglandular and stromal) were recorded by the extent of inflammation (focal, multifocal or diffuse) and the grade of inflammation (mild, moderate and severe). And the most dominant inflammation pattern of one patient was defined as the histological structure with the most extent and grade of inflammation. Then, we chose the tissue slice with the most dominant inflammation pattern for immunohistochemistry (IHC). IHC was performed using antibodies decorating T-lymphocytes (CD3, rabbit polyclonal Ab A0452; antigen retrieval, pH 6.0; 1:300; Dako; Corp.: Abcam; Cambridge, USA), B-lymphocytes (CD20, mouse monoclonal Ab clone L26; antigen retrieval, pH 6.0; 1/500; Dako; Corp.: Abcam; Cambridge, USA), and macrophages (CD68, mouse monoclonal Ab clone 10D6; antigen retrieval, pH 6.0; 1:800; Novocastra-Menarini; Corp.: Abcam; Cambridge, USA). The proportion of T-lymphocytes, B-lymphocytes and macrophages less than 5% in all cells per high magnification was defined as no infiltration, which was also back to back reviewed by the pathologists. We used SPSS v21.0 software (Corp.: IBM; Armonk, USA) for statistical description and analysis. The Kolmogorov-Smirnov test determined the normality of the continuous variables. Mean and range presented continuous variables; the Student t-test or Mann-Whitney U-test compared the differences between the two groups. Frequency and percentile were used to present categorical or ranked variables; the Fisher exact test was used to test the differences. Logistic regression analysis was performed in multivariate analysis. All reported P values are two sided, and P<0.05 was considered statistically significant.

Results

Characteristics of BPH patients

The present study included 76 BPH patients with the mean age of 69.5 years old (range, 49–83 years) and the mean body mass index (BMI) of 24.47 kg/m2 (range, 19.03–38.09 kg/m2). The mean total prostate volume and preoperative serum prostate-specific antigen (PSA) of the study cohort were 91 mL (range, 24–218 mL) and 5.86 ng/mL (range, 0.73–17.97 ng/mL). There were 36 patients having hypertension and 9 patients suffering from diabetes. Twenty patients received prostate biopsies before surgery due to the elevated serum PSA.

Characteristics of inflammatory infiltration in hyperplasic prostatic tissues

According to the H&E staining, all the hyperplasic prostatic tissues had inflammatory cells infiltration (). There were 23.7% (18/76) patients, 5.3% (4/76) patients and 11.8% (9/76) patients had no inflammation in glandular, in periglandular and in stromal, respectively. Therefore, periglandular inflammation was the most common histologic type, being presented in 94.7% of patients, followed by stromal inflammation (67/76, 88.2%) and glandular inflammation (57/76, 75.0%).
Figure 1

Glandular, periglandular and stromal inflammatory infiltration of varying degrees (H&E staining, ×200). (A,B,C) Glandular inflammation: (A) grade 1 (mild, in 51.3% patients); (B) grade 2 (moderate, in 22.4% patients); (C) Grade 3 (severe, in 1.3% patients). (D,E,F) Periglandular inflammation: (D) grade 1 (mild, in 46.1% patients); (E) grade 2 (moderate, in 42.1% patients); (F) grade 3 (Severe, in 6.6% patients). (G,H,I) Stromal inflammation: (G) grade 1 (mild, in 35.5% patients); (H) grade 2 (moderate, in 38.2% patients); (I) grade 3 (severe, in 14.5% patients).

Glandular, periglandular and stromal inflammatory infiltration of varying degrees (H&E staining, ×200). (A,B,C) Glandular inflammation: (A) grade 1 (mild, in 51.3% patients); (B) grade 2 (moderate, in 22.4% patients); (C) Grade 3 (severe, in 1.3% patients). (D,E,F) Periglandular inflammation: (D) grade 1 (mild, in 46.1% patients); (E) grade 2 (moderate, in 42.1% patients); (F) grade 3 (Severe, in 6.6% patients). (G,H,I) Stromal inflammation: (G) grade 1 (mild, in 35.5% patients); (H) grade 2 (moderate, in 38.2% patients); (I) grade 3 (severe, in 14.5% patients). In addition, we recorded three grades of inflammatory cells infiltration for different histologic types: mild, moderate and severe. Among the samples with glandular inflammation, mild inflammation accounted for 51.3% (39/76), moderate inflammation accounted for 22.4% (17/76) and severe inflammation accounted for 1.3% (1/76), respectively. For periglandular inflammation samples, mild inflammation accounted for 46.1% (35/76). Moderate and severe inflammation accounted for 42.1% (32/76) and 6.6% (5/76). Stromal inflammation was detected in severe degree for 14.5% (11/76), in moderate grade for 38.2% (29/76), in mild degree for 35.5% (27/76). We also assessed the extent of inflammation of prostate in the present study. The histopathological criteria that we referred was originated from the chronic prostatitis. Different from that of the chronic prostatitis, the extent of inflammation in BPH is mainly multifocal infiltration and scarcely focal infiltration or diffuse infiltration. Univariable and multivariable regression were performed to analyze influence factors of prostate volume adjusted for the grades of each inflammatory pattern, age, and complications (). Univariable regression analysis revealed prostate volume was significantly associated with grading of glandular, periglandular and stromal inflammation, also with age. Multiple regression analysis identified grading of glandular inflammation (P=0.015) and stromal inflammation (P=0.037) were independently correlated with prostate volume. The patients had more severe periglandular inflammation tending to have larger prostate volume without reaching statistical significance (P=0.082).
Table 1

Univariable and multiple regression analysis of prostate volume

VariablesUnivariable regression analysisMultivariable regression analysis
Co-efficient   P valueCo-efficientP value
Age0.3230.004*0.2620.010*
Hypertension0.2280.047*0.1910.059
Diabetes0.1200.303
Grading of glandular inflammation0.3570.002*0.2510.015*
Grading of periglandular inflammation0.3680.001*0.1800.082
Grading of stromal inflammation0.3370.003*0.2170.037*

P value was analyzed by univariate or multivariate regression analysis. *, P<0.05.

P value was analyzed by univariate or multivariate regression analysis. *, P<0.05. IHC was performed to further analyze the distribution of different inflammatory cells (). We found that there were differences in distribution of the three types of inflammatory cells at glandular (P=0.003), periglandular (P<0.001) and stromal (P<0.001). There were higher rates of T-lymphocytes and macrophages in the glandular infiltration. The proportion of T-lymphocytes and B-lymphocytes was higher in the periglandular infiltration. In the stromal section, the infiltrations of T-lymphocytes and macrophages were more common (). Then, patients were divided into two groups on the categories of prostatic hyperplasia as glandular hyperplasia dominated and stromal hyperplasia dominated (12,13) (). According to the Chi-square test, stromal hyperplasia dominated was only significantly correlated with the condition of stromal T-lymphocytes infiltration (P<0.001) ().
Figure 2

T-lymphocytes, B-lymphocytes and macrophages infiltration of varying degrees [CD3 staining in (A,B,C), CD20 staining in (D,E,F), CD68 staining in (G,H,I); IHC, ×200]. (A,B,C) T-lymphocytes infiltration: (A) glandular (in 27.6% patients); (B) periglandular (in 77.6% patients); (C) stromal (in 55.3% patients). (D,E,F) B-lymphocytes inflammation: (D) glandular (in 35.5% patients); (E) periglandular (in 38.2% patients); (F) stromal (in 14.5% patients). (G,H,I) Macrophages infiltration: (G) glandular (in 26.3% patients); (H) periglandular (in 28.9% patients); (I) stromal (in 22.4% patients).

Table 2

Comparison of the distribution of different inflammatory cells

VariablesT-lymphocytes (N=76)B-lymphocytes (N=76)Macrophages (N=76)P value
Glandular infiltration, n (%)0.003*
   No55 (72.4)70 (92.1)56 (73.7)
   Yes21 (27.6)6 (7.9)20 (26.3)
Periglandular infiltration, n (%)<0.001*
   No17 (22.4)28 (36.8)54 (71.1)
   Yes59 (77.6)48 (63.2)22 (28.9)
Stromal infiltration, n (%)<0.001*
   No34 (44.7)45 (59.2)59 (77.6)
   Yes42 (55.3)31 (40.8)17 (22.4)

P value was analyzed by Chi-square test analysis. *, P<0.05.

Figure S1

Representative histological photomicrographs of epithelial or stromal hyperplasia of BPH specimens (H&E staining, ×100). In the epithelial hyperplasia-dominant BPH patients’ tissue, tall columnar prostatic epithelial cells are often seen, with prominent hyperplasia protruding into the glandular cavity. There is a marked increase in glands with glandular (adenomatous) nodules or mixed nodules around the glands. In the stromal hyperplasia-dominant BPH patients’ tissue, stromal thickening/nodules, adenomyoid-type nodules, or fibroadenoma type nodules are often seen. (A) Representative histological photomicrographs of epithelial hyperplasia; (B) representative histological photomicrographs of stromal hyperplasia. BPH, benign prostatic hyperplasia.

Table 3

Comparison of the distribution of inflammatory cells in different pathological types

VariablesT-lymphocytesB-lymphocytesMacrophages
Glandular hyperplasia dominated (N=44)Stromal hyperplasia dominated (N=32)P valueGlandular hyperplasia dominated (N=44)Stromal hyperplasia dominated (N=32)P valueGlandular hyperplasia dominated (N=44)Stromal hyperplasia dominated (N=32)P value
Glandular infiltration, n (%)0.6620.2040.453
   No31 (70.5)24 (75.0)42 (95.5)28 (87.5)31 (70.5)25 (78.1)
   Yes13 (29.5)8 (25.0)2 (4.5)4 (12.5)13 (29.5)7 (21.9)
Periglandular infiltration, n (%)0.1130.5600.706
   No7 (15.9)10 (31.3)15 (34.1)13 (40.6)32 (72.7)22 (68.8)
   Yes37 (84.1)22 (68.8)29 (65.9)19 (59.4)12 (27.3)10 (31.3)
Stromal infiltration, n (%)<0.001*0.1640.639
   No28 (63.6)6 (18.8)29 (65.9)16 (50.0)35 (79.5)24 (75.0)
   Yes16 (36.4)26 (81.3)15 (34.1)16 (50.0)9 (20.5)8 (25.0)

P value was analyzed by Chi-square test analysis. *, P<0.05.

T-lymphocytes, B-lymphocytes and macrophages infiltration of varying degrees [CD3 staining in (A,B,C), CD20 staining in (D,E,F), CD68 staining in (G,H,I); IHC, ×200]. (A,B,C) T-lymphocytes infiltration: (A) glandular (in 27.6% patients); (B) periglandular (in 77.6% patients); (C) stromal (in 55.3% patients). (D,E,F) B-lymphocytes inflammation: (D) glandular (in 35.5% patients); (E) periglandular (in 38.2% patients); (F) stromal (in 14.5% patients). (G,H,I) Macrophages infiltration: (G) glandular (in 26.3% patients); (H) periglandular (in 28.9% patients); (I) stromal (in 22.4% patients). P value was analyzed by Chi-square test analysis. *, P<0.05. P value was analyzed by Chi-square test analysis. *, P<0.05. We also did further analysis to see if there was a relationship between the specific type of immune cell infiltration and prostate volume (). We found stromal T-lymphocytes infiltration had a trend of correlation with prostate volume (P=0.077), while periglandular macrophages infiltration had a trend of correlation with prostate volume (P=0.050).
Table S2

Further analysis on the association of different type of immune cell infiltration and prostate volume

VariablesT-lymphocytesB-lymphocytesMacrophages
Number, n (%)Prostate volume (mL)P valueNumber, n (%)Prostate volume (mL)P valueNumber, n (%)Prostate volume (mL)P value
Glandular infiltration0.3930.5580.218
   No55 (72.4)90.4270 (92.1)91.5056 (73.7)85.09
   Yes21 (27.6)95.856 (7.9)96.8320 (26.3)111.05
Periglandular infiltration0.7990.0780.050
   No17 (22.4)90.4528 (36.8)79.1654 (71.1)83.69
   Yes59 (77.6)92.3548 (63.2)99.3622 (28.9)112.13
Stromal infiltration0.0770.9770.924
   No34 (44.7)81.3845 (59.2)92.0659 (77.6)91.65
   Yes42 (55.3)100.4631 (40.8)91.7317 (22.4)92.88

P value was analyzed by t-test analysis.

Inflammation and metabolism

A central feature of obesity is systemic chronic inflammation (14). In the process of chronic inflammation of obese adipose tissue, a variety of immune cells are involved. Therefore, obesity may also affect the distribution of inflammatory cells in BPH (15). We divided patients into two groups according to whether they were overweight (BMI >25 kg/m2) (). We found that overweight patients had higher glandular inflammation infiltration rate in the prostate (P=0.010).
Table 4

Relationship between obesity and the distribution of inflammatory cells in the prostate

VariablesObesityP value
NoYes
Glandular inflammation0.010*
   Mild40 (85.1)17 (58.6)
   Moderate–severe7 (14.9)12 (41.4)
Periglandular inflammation0.706
   Mild19 (40.4)13 (44.8)
   Moderate–severe28 (59.6)16 (55.2)
Stromal inflammation0.521
   Mild24 (51.1)17 (58.6)
   Moderate–severe23 (48.9)12 (41.4)

P value was analyzed by Chi-square test analysis. *, P<0.05.

P value was analyzed by Chi-square test analysis. *, P<0.05.

Inflammation and serum PSA level

Univariable regression analysis was used to compare total serum PSA level among the grades of each inflammatory pattern, age, and prostate volume, which revealed total serum PSA level was significant associated with grading of glandular, periglandular and stromal inflammation, also with prostate volume. According to the multivariate analysis, the grade of glandular inflammation (P=0.031) could independently increase serum PSA level apart from the prostate volume ().
Table 5

Univariable and multiple regression analysis of total serum PSA level

VariablesUnivariable regression analysisMultiple regression analysis
Co-efficient   P valueCo-efficientP value
Age0.1290.268
Prostate volume0.3310.003*0.2710.035*
Grading of glandular inflammation0.2640.021*0.2480.031*
Grading of periglandular inflammation0.3610.001*0.1060.356
Grading of stromal inflammation0.3450.002*0.2160.061

P value was analyzed by univariate or multivariate regression analysis. *, P<0.05. PSA, prostate-specific antigen.

P value was analyzed by univariate or multivariate regression analysis. *, P<0.05. PSA, prostate-specific antigen. We also did further analysis to see if there was a relationship between the specific type of immune cell infiltration and serum PSA level (). We found glandular and periglandular T-lymphocytes infiltration were correlated with serum PSA level significantly (P=0.003, 0.001, respectively).
Table S3

Further analysis on the association of different type of immune cell infiltration and total serum PSA level

VariablesT-lymphocytesB-lymphocytesMacrophages
Number, n (%)Mean PSAP valueNumber, n (%)Mean PSAP valueNumber, n (%)Mean PSAP value
Glandular infiltration0.003*0.5580.218
   No55 (72.4)4.8370 (92.1)5.9156 (73.7)5.96
   Yes21 (27.6)8.576 (7.9)5.2820 (26.3)5.58
Periglandular infiltration0.001*0.5620.920
   No17 (22.4)4.5928 (36.8)4.9854 (71.1)5.59
   Yes59 (77.6)6.2348 (63.2)6.3822 (28.9)6.53
Stromal infiltration0.0540.9100.792
   No34 (44.7)5.0745 (59.2)6.1159 (77.6)5.78
   Yes42 (55.3)6.5031 (40.8)5.5117 (22.4)6.16

P value was analyzed by t-test analysis. *, P<0.05. PSA, prostate-specific antigen.

Discussion

Histologic inflammatory infiltration is a universal histopathology in prostatic specimens (14,16). Our investigation revealed that all specimens derived from TURP surgery had histological inflammation, although all of our patients neither have clinical signs of prostatitis nor any correlation with urinary infection. Results from multicentric clinical trials such as REDUCE also showed histologic inflammation affected 77.6% of 8,224 patients respectively (17-19). The frequently observed inflammatory cells in periglandular section indicate the genesis of immune response in prostate may proceed from this area. Epithelial injury could cause the periglandular tissue exposed to secretion products of the prostate which has a high proteolytic activity. They could destroy connective tissue cells and digest major matrix areas, allowing broad access of autoantigenic molecules to the immune system of the prostate (15,20,21). Stimuli such as infectious agents or urinary reflux, metabolic syndrome, aging processes, and autoimmune responses can also cause prostatic immune dysregulation through the development of multiple molecular pathways involved in inflammatory infiltration (9). Therefore, BPH could be an immune inflammatory disease. In our study, the predominant cell type in BPH tissue is T-lymphocytes, which was identified in 96.1% of all specimens, followed by B-lymphocytes in 77.6% and macrophages in 52.6% of all specimens. Previous studies revealed that inflammatory infiltrates consisted of 70% T-lymphocytes, 15% B-lymphocytes, and 15% macrophages (20,22). The increased frequency and density of T-lymphocytes in BPH tissue suggested that the initial immune response in prostate might be cell-mediated immunity. Previous studies showed B-lymphocytes and macrophages probably participate in antigen presentation and autoimmune response (23-25). Although previous studies revealed patients with prostatic inflammation had larger prostate volumes, higher International Prostate Symptom Score (IPSS) and greater risk of acute urinary retention than those without inflammation (10,18,19,26), it is still unclear that which histologic section or immune cells subtype infiltration is relevant with prostate volume. In our study, the multiple regression analysis results showed age, degree of glandular and stromal inflammation would be the most important factors contributing to increased prostate volume. The aggressiveness of the glandular and stromal inflammation can cause tissue destruction and upregulated many proinflammatory cytokines. Inflammatory cells infiltration releases a number of cytokines and growth factors and induces tissue rebuilding and cellular proliferation. This wound-healing process could contribute to the prostate hyperplasia and might explain the pathogenesis of BPH. T-lymphocytes may be a key component in BPH. In vitro experiment showed activated T-lymphocytes from BPH tissues expressed significant amounts of proinflammatory cytokines and T cell-derived cytokines, such as IL-2, IL-4, IL-17 and interferon-γ, which caused the proliferation of BPH stromal cells (27-31). Also, stromal cells could express cytokine IL-15, which stimulate the growth of memory T-lymphocytes and maintain the T-lymphocytes infiltrate in BPH tissue, resulting in an increased recruitment of more T-lymphocytes into BPH stromal areas and proliferation of stromal cells (32). Our study revealed stromal hyperplasia was significantly correlated with the degree of stromal inflammation and stromal T-lymphocytes infiltration, which reconfirmed the relationship between T-lymphocytes infiltration and stromal hyperplasia through the pathological and morphological phenomenon. Epidemiological evidence suggests that prostatic inflammation associated with BPH is likely to be caused by metabolic stress signals, while obesity and metabolic syndrome may be associated with the development of BPH (33-35) and LUTS (36). In Tyagi et al.’s research, elevated urinary chemokines supported BPH as a metabolic disorder, suggesting a molecular link between BPH/LUTS and inflammation of the prostate (37). Previous studies have pointed out that obesity itself is a chronic inflammatory state. Due to the changes of metabolism in obese patients, the systemic inflammatory state may be changed and might cause the increased prevalence of BPH (38). Our studies suggest that obese patients have increased prostate glandular inflammation infiltration. One possible reason is, obese patients have changed immune status, promoting the increase of inflammatory cells infiltration in prostate. Another possible reason is obese patients have more significant glandular changes in prostate, secreting more chemokines, and induce prostate inflammatory cells infiltration. Therefore, changes in the immune system and metabolism may be part of the reasons for prostate inflammation and BPH. More research is needed to confirm this relationship. As we know, an increase in PSA is associated with aging and prostate volume. In addition to age and prostate volume, inflammatory cell infiltration may also be a factor in PSA elevation. Inflammation might be present in a significant proportion of patients with elevated serum PSA level (39,40). Previous studies showed that the elevation of PSA levels was correlated with the glandular inflammatory infiltration (13). However, which type of immune cell is most responsible for the elevated serum PSA level was not mentioned. Our study showed grading of glandular inflammation and glandular T-lymphocytes infiltration were correlated with serum PSA level significantly. The difference between Grade 0 and Grade 2 glandular inflammation did reach statistical significance. We assumed the prostate epithelium remains its integrity when the inflammation is mild (Grade 1). With the histologic aggressiveness grading of glandular inflammation, prostatic epithelial cells surrounding the affected area might be damaged and PSA stored in the epithelial cells released into the blood circulation result in the abnormal serum PSA elevation. Glandular T-lymphocytes infiltration plays an important role in disruption of the prostatic glandular epithelium (19). Total amount of T-lymphocytes in prostate might affect serum PSA level. There are more T-lymphocytes in the stroma than the gland, so the sampling error may lead to this bias. The present study has some limitations. Firstly, prostatic hyperplasia mainly occurs in the transitional zone of the prostate gland, which is also the main area to be removed during TURP surgery. TURP excision tissue can be used to study inflammation of BPH (7). Meanwhile, the published literatures use the similar method to analyze the inflammatory condition of BPH tissues (7). But the limitations could not be ignored: the sampling method failed to exactly localize the inflammation condition on the transitional zone of the prostate. Secondly, we mainly studied the relationship between total inflammatory infiltration and clinical indicators, and the relationship between T-lymphocytes, B-lymphocytes and macrophages of inflammatory cells and clinical indicators. In the future, it is necessary to study the relationship between subtypes of inflammatory cells (M1/M2 macrophages, CD4/CD8+ T-lymphocytes) and clinical indicators. Thirdly, as a single-center retrospective study, the sample size should be further increased in the future and multiple indicators should be analyzed to better describe the situation of inflammatory cells in BPH tissues.

Conclusions

We characterized infiltrated patterns of different inflammatory cells in histological structures of hyperplasic prostatic tissues from surgically treated BPH specimens. The role of inflammation in BPH development was highlighted by its correlation with the prostate volume, metabolism and PSA level. P value was analyzed by t-test analysis. P value was analyzed by t-test analysis. *, P<0.05. PSA, prostate-specific antigen. Representative histological photomicrographs of epithelial or stromal hyperplasia of BPH specimens (H&E staining, ×100). In the epithelial hyperplasia-dominant BPH patients’ tissue, tall columnar prostatic epithelial cells are often seen, with prominent hyperplasia protruding into the glandular cavity. There is a marked increase in glands with glandular (adenomatous) nodules or mixed nodules around the glands. In the stromal hyperplasia-dominant BPH patients’ tissue, stromal thickening/nodules, adenomyoid-type nodules, or fibroadenoma type nodules are often seen. (A) Representative histological photomicrographs of epithelial hyperplasia; (B) representative histological photomicrographs of stromal hyperplasia. BPH, benign prostatic hyperplasia. The article’s supplementary files as
  37 in total

1.  Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.

Authors:  G Theyer; G Kramer; I Assmann; E Sherwood; W Preinfalk; M Marberger; O Zechner; G E Steiner
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

Review 2.  Pathology of benign prostatic hyperplasia.

Authors:  C G Roehrborn
Journal:  Int J Impot Res       Date:  2008-12       Impact factor: 2.896

Review 3.  The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).

Authors:  Giorgio Gandaglia; Alberto Briganti; Paolo Gontero; Nicola Mondaini; Giacomo Novara; Andrea Salonia; Alessandro Sciarra; Francesco Montorsi
Journal:  BJU Int       Date:  2013-04-12       Impact factor: 5.588

Review 4.  The progression of benign prostatic hyperplasia: examining the evidence and determining the risk.

Authors:  J B Anderson; C G Roehrborn; J A Schalken; M Emberton
Journal:  Eur Urol       Date:  2001-04       Impact factor: 20.096

5.  Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination.

Authors:  G Karazanashvili; L Managadze
Journal:  Eur Urol       Date:  2001-05       Impact factor: 20.096

Review 6.  The role of prostatic inflammation in the development and progression of benign and malignant diseases.

Authors:  Giorgio Gandaglia; Emanuele Zaffuto; Nicola Fossati; Vito Cucchiara; Vincenzo Mirone; Francesco Montorsi; Alberto Briganti
Journal:  Curr Opin Urol       Date:  2017-03       Impact factor: 2.309

7.  The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

Authors:  J Curtis Nickel; Claus G Roehrborn; Michael P O'Leary; David G Bostwick; Matthew C Somerville; Roger S Rittmaster
Journal:  Eur Urol       Date:  2007-11-20       Impact factor: 20.096

Review 8.  Benign prostatic hyperplasia.

Authors:  Bilal Chughtai; James C Forde; Dominique Dana Marie Thomas; Leanna Laor; Tania Hossack; Henry H Woo; Alexis E Te; Steven A Kaplan
Journal:  Nat Rev Dis Primers       Date:  2016-05-05       Impact factor: 52.329

9.  Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.

Authors:  J Curtis Nickel; Claus G Roehrborn; Michael P O'leary; David G Bostwick; Matthew C Somerville; Roger S Rittmaster
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

10.  Relationship among diet habit and lower urinary tract symptoms and sexual function in outpatient-based males with LUTS/BPH: a multiregional and cross-sectional study in China.

Authors:  Yuke Chen; Wei Yu; Liqun Zhou; Shiliang Wu; Yang Yang; Jianye Wang; Ye Tian; Dalin He; Yong Xu; Jian Huang; Xiaofeng Wang; Xin Gao; Hanzhong Li; Lulin Ma; Ning Zhang; Shengtian Zhao; Xunbo Jin
Journal:  BMJ Open       Date:  2016-08-31       Impact factor: 2.692

View more
  5 in total

1.  E-cadherin expression is inversely correlated with aging and inflammation in the prostate.

Authors:  Laura E Pascal; Rajiv Dhir; Goundappa K Balasubramani; Wei Chen; Chandler N Hudson; Pooja Srivastava; Anthony Green; Donald B DeFranco; Naoki Yoshimura; Zhou Wang
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

2.  Analysis of the relationship between asthma and benign prostatic hyperplasia: A STROBE-compliant study.

Authors:  Jee Hye Wee; Woo Jin Bang; Min Woo Park; Soo-Hwan Byun; Hyo Geun Choi
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

Review 3.  The Role of Periprostatic Adipose Tissue on Prostate Function in Vascular-Related Disorders.

Authors:  Gabriela Reolon Passos; Ana Carolina Ghezzi; Edson Antunes; Mariana Gonçalves de Oliveira; Fabiola Zakia Mónica
Journal:  Front Pharmacol       Date:  2021-02-12       Impact factor: 5.810

Review 4.  Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging.

Authors:  Dehong Cao; Ruonan Sun; Lei Peng; Jinze Li; Yin Huang; Zeyu Chen; Bo Chen; Jin Li; Jianzhong Ai; Lu Yang; Liangren Liu; Qiang Wei
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

Review 5.  COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality.

Authors:  Radheshyam Maurya; Prince Sebastian; Madhulika Namdeo; Moodu Devender; Arieh Gertler
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.